1-5 of 5
Mamoun Dib, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Bortezomib and High-Dose Melphalan Vs. High-Dose Melphalan As Conditioning Regimen before Autologous Stem Cell Transplantation in De Novo Multiple Myeloma Patients: A Phase 3 Study of the Intergroupe Francophone Du Myelome (IFM 2014-02)

Murielle Roussel, Benjamin Hebraud, MD, Valerie Lauwers-Cances, MD, Margaret Macro, MD, Xavier Leleu, MD PhD, Cyrille Hulin, MD, Lionel Karlin, MD, Bruno Royer, MD, Aurore Perrot, MD, Philippe Moreau, MDPhD, Denis Caillot, MD, Sophie Rigaudeau, MD, Mamoun Dib, MD, Emmanuelle Nicolas-Virelizier, MD, Martine Escoffre-Barbe, MD, Karim Belhadj, MD, Brigitte Pegourie, MD, Anne-Marie Stoppa, MD, Carla Araujo, MD, Chantal Doyen, MD, Jean Fontan, MD, Brigitte Kolb, MD, Laurent Garderet, MD PhD, Sabine Brechignac, MD, Jean Valere Malfuson, MD, Veronique Dorvaux, MD, Pascal Lenain, MD, Omar Benbrahim, MD, Arnaud Jaccard, Cecile Borel, MD, Herve Avet Loiseau, MD PhD, Michel Attal, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 398.
https://doi.org/10.1182/blood.V130.Suppl_1.398.398
Published: 2017
Journal Articles

A Prospective Phase II Trial of Lenalidomide and Dexamethasone ( LEN-DEX) in POEMS Syndrome

Arnaud Jaccard, MD, Anne Lazareth, MD, Lionel Karlin, MD, Sylvain Choquet, MD, Laurent Frenzel, MD, Laurent Garderet, MD, Mamoun Dib, MD, Lionel Galicier, MD, Olivier Tournilhac, MD, Karim Belhadj, Philippe Moreau, MD, Olivier Decaux, MD PhD, Lotfi Benboubker, MD PhD, Michel Cogné, MD PhD, Lucile Musset, MD, Jean Paul Fermand, MD
Journal: Blood
Blood (2014) 124 (21): 36.
https://doi.org/10.1182/blood.V124.21.36.36
Published: 2014
Journal Articles

Lost and Gain of t(4;14) and t(11;14) in Multiple Myeloma Patients Between Relapse and diagnosis: An Illustration of Clonal Dynamic During Disease Course. an IFM Study

Benjamin Hebraud, MD, Denis Caillot, M.D., Jill Corre, Gerald Marit, MD, Cyrille Hulin, MD, Xavier Leleu, MD, PhD, Marc Wetterwald, MD, PhD, Mamoun Dib, MD, Philippe Rodon, MD, Laurent Voillat, MD, Bruno Royer, MD, Eric G. Voog, MD, Anne-Marie Stoppa, MD, Laurent Garderet, MD, Brigitte Kolb, MD, Michel Maigre, MD, Boullanger FOW HENG Nadine, Olivier Allangba, Thierry Facon, MD, Claire Mathiot, MD, Michel Attal, MD, Philippe Moreau, MD, Herve avet-Loiseau, MD
Journal: Blood
Blood (2012) 120 (21): 196.
https://doi.org/10.1182/blood.V120.21.196.196
Published: 2012
Journal Articles

Risk Factors of Thromboembolic Events in Multiple Myeloma Treated with IMiDs-Based Therapy While on LMWH Prophylaxis,

Xavier Leleu, MD, PhD, Simona Iacobelli, Alain Barrois, Benjamin Pelle, Liz Clark, Eileen Boyle, MD, Philippe Moreau, MD, Mamoun Dib, MD, Denis Caillot, MD, Dietger Niederwieser, MD, Tamas Masszi, MD, PhD, Jean Fontan, MD, Chantal Doyen, MD, Roman Hajek, MD, PhD, Francesco Onida, Heinz Ludwig, MD, Theo M. de Witte, MD, Gosta Gahrton, MD, Curly TCM Morris, MD, Laurent Garderet, MD
Journal: Blood
Blood (2011) 118 (21): 3340.
https://doi.org/10.1182/blood.V118.21.3340.3340
Published: 2011
Journal Articles

Melphalan-Prednisone-Thalidomide (MP-T) Demonstrates a Significant Survival Advantage in Elderly Patients ≥75 Years with Multiple Myeloma Compared with Melphalan-Prednisone (MP) in a Randomized, Double-Blind, Placebo-Controlled Trial, IFM 01/01.

Cyrille Hulin, MD, Thierry Facon, MD, Philippe Rodon, MD, Brigitte Pegourie, MD, Lotfi Benboubker, MD, Chantal Doyen, MD, Mamoun Dib, MD, Gael Guillerm, MD, Laurent Voillat, MD, Claire Mathiot, MD, Philippe Casassus, MD, Olivier Decaux, MD, Michel Flesch, MD, Laurent Garderet, MD, Philippe Moreau, MD
Journal: Blood
Blood (2007) 110 (11): 75.
https://doi.org/10.1182/blood.V110.11.75.75
Published: 2007